In Allergan Insider Trade Ruling, Questions Upstage Answers
By Karlee Weinmann (November 5, 2014, 2:46 PM EST) -- Uncertainty tinged a much-anticipated California federal court ruling that on Tuesday added contours to the debate over whether Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman flouted securities laws in their joint takeover bid for Allergan Inc., keeping each of the parties on shaky ground.
U.S. District Judge David Carter noted "serious questions" that the unorthodox partnership between Valeant and Ackman — whose Pershing Square Capital Management LP holds a 9.7 percent Allergan stake — violated securities rules. It's the firmest stance from the court since the target company filed its suit in June, setting in motion landmark securities litigation....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!